Skip to main content

Advertisement

Table 5 KEGG biological pathways for differentially expressed genes in different stages

From: Peripheral arterial occlusive disease: Global gene expression analyses suggest a major role for immune and inflammatory responses

KEGG Pathway Name Pathway ID Genes involved P-Value
For intermediate lesions    
Type I Diabetes Mellitus(TIDM) Hsa04940 9 0.002
Antigen Processing and Presentation(APP) Hsa04612 13 0.003
Complement and Coagulation Cascades(CCC) Hsa04610 12 0.003
Cell Adhesion Molecules(CAM) Hsa04514 17 0.005
Toll-Like Receptor Signaling Pathway(TLR) Hsa04620 13 0.013
Natural Killer Cell Mediated Cytotoxicity(NK) Hsa04650 15 0.029
For advanced lesions    
Focal Adhesion(FA) Hsa04510 25 0.000
ECM-Receptor Interaction(ECM) Hsa04512 15 0.000
Toll-Like Receptor Signaling Pathway(TLR) Hsa04620 13 0.002
Regulation of Actin Cytoskeleton(RAC) Hsa04810 20 0.005
Fc Epsilon RI Signaling Pathway(FER) Hsa04664 10 0.012
MAPK Signaling Pathway(MAPK) Hsa04010 22 0.019
Natural Killer Cell Mediated Cytotoxicity(NK) Hsa04650 13 0.021
Long-Term Potentiation(LTP) Hsa04720 8 0.030
Cell Communication(CC) Hsa01430 12 0.032
B Cell Receptor Signaling Pathway(BCR) Hsa04662 8 0.042
  1. Genes identified from SAM under FDR<1% were tested for overrepresentation within the pathways for the KEGG under the modified Fisher Exact test assumption; p-Value and genes involved in the pathway are provided for each pathway